Skip to main content
Extendicare Inc. (EXETF)
OTCMKTS · Delayed Price · Currency is USD
16.12
+0.37 (2.35%)
At close: Dec 5, 2025

Extendicare Revenue

Extendicare had revenue of 440.28M CAD in the quarter ending September 30, 2025, with 22.62% growth. This brings the company's revenue in the last twelve months to 1.59B, up 11.59% year-over-year. In the year 2024, Extendicare had annual revenue of 1.47B with 12.36% growth.

Revenue (ttm)
1.59B CAD
Revenue Growth
+11.59%
P/S Ratio
1.18
Revenue / Employee
67.66K CAD
Employees
23,500
Market Cap
1.35B USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.47B161.25M12.36%
Dec 31, 20231.30B83.38M6.83%
Dec 31, 20221.22B54.59M4.68%
Dec 31, 20211.17B63.44M5.75%
Dec 31, 20201.10B-28.41M-2.51%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Veradigm 588.02M
Elite Pharmaceuticals 122.89M
Glass House Brands 196.17M
American Oncology Network 1.76B
Northwest Biotherapeutics 937.00K
Silence Therapeutics 25.83M
Global Cord Blood 196.10M
Zomedica 29.45M
Revenue Rankings

Extendicare News

More News